Bloomberg Law Webinar: Interpreting Myriad: Gene Patenting and Other Inventions at Risk

Bloomberg Law Webinar: Interpreting Myriad: Gene Patenting and Other Inventions at Risk

Speaking Engagement

The webinar will provide an assessment of the June 13, 2013 Supreme Court opinion in Association for Molecular Pathology v. Myriad Genetics Inc. The court considered a fundamental question: Are human genes patentable? But the patent community had a broader concern-the high court's recent statements that seem to question patent eligibility on a number of other fronts. Did the justices limit their review or did they deal a significant blow to a broad swath of patents?

WilmerHale Partner Thomas Saunders will serve on a panel to review the legal arguments and gauge the potential impact on biotechnology and other markets.

Read More About the Event

Speakers

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.